The nasal vaccine: the next solution envisaged by the government to end the pandemic?

Although the majority of health restrictions have now been lifted in France, this does not mean that this is the end of the Covid-19 pandemic… Indeed, despite confinements, curfews and vaccines, the virus unfortunately continues to circulate in France and around the world.

To succeed in putting a real brake on the pandemic, the United States is therefore organizing a second world summit on Covid-19 this Thursday, May 12. The goal ? Allow to “redouble our collective efforts to end the acute phase of the pandemic and prepare for future health threats”, according to the White House.

The nasal vaccine, the solution?

Among the solutions that could be considered to “put an end” to the pandemic, the nasal (or mucous) vaccine could be preferred. And for good reason, questioned by our colleagues from HuffPostthe immunologist Morgane Bomsel indicated that “several studies show that the classic vaccines, intramuscular, produce very few antibodies at the level of the mucous membranes”.

A real concern insofar as these are the areas (inside the nose, mouth, etc.) that the virus enters the body. Thus, “this reinforces the idea that a mucosal vaccine could be much more effective than those by injection in reducing transmission”, believes the researcher.

In France, the project for a nasal anti-Covid vaccine has already started. Developed by a joint research team from Inrae and the University of Tours, it is now piloted by the start-up Lovaltech, which plans to market it in late 2023 or early 2024.

See also: Singer Alizée, very cash on vaccination…

Lisa Ziane

Leave a Comment